Health IT Analytics August 28, 2019
Jessica Kent

– As part of a four-year NIH study, Baylor College of Medicine has created guidelines for future efforts in precision medicine that aim to deliver personalized care.

NIH’s Electronic Medical Records and Genomics (eMERGE III) program coordinated activities at 11 clinical participant enrollment sites, with two sequencing centers and a coordinating center to analyze the DNA of more than 25,000 participants.

The Baylor College of Medicine Human Genome Sequencing Center was one of two Centralized Sequencing and Genotyping (CSG) Facilities, conducting the data analysis, generation, and clinical data reporting for more than 14,500 of the 25,000 participants in the program.

At clinical trial sites, participants submitted a blood sample and their DNA was sequenced using a custom...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Health System / Hospital, Physician, Precision Medicine, Provider, Technology
23andMe: What If …
23andMe CEO Anne Wojcicki considers taking company private
Age of Opportunity: Artificial Intelligence and the Precision Medicine Future
Opinion: Readers respond to OTC antidepressants, personalized medicine, restoring trust in public health, and more
Precision medicine approach combining AI, DNA and drug testing shows gains against relapsed childhood cancers

Share This Article